| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/15/2000 | US6024964 Membrane anchor/active compound conjugate, its preparation and its uses |
| 02/15/2000 | US6024963 Potentiation of immunogenic response |
| 02/15/2000 | US6024957 Immunomodulators and methods for the prevention and reversal of organ transplant rejection using same |
| 02/15/2000 | US6024956 Interleukins and antiinflammatrory agents |
| 02/15/2000 | CA2197739C 1,4-dihydropyridine compounds |
| 02/10/2000 | WO2000007014A2 Leptin-mediated gene-induction |
| 02/10/2000 | WO2000006730A2 Human cytoskeletal proteins |
| 02/10/2000 | WO2000006729A1 Kdel receptor inhibitors |
| 02/10/2000 | WO2000006709A1 Human protein kinase h2lau20 |
| 02/10/2000 | WO2000006694A2 Compound and method for the prevention and/or the treatment of allergy |
| 02/10/2000 | WO2000006589A1 Prostate derived ets factor |
| 02/10/2000 | WO2000006588A1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS |
| 02/10/2000 | WO2000006577A1 OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLIN-4-AMINES AND ANALOGS THEREOF |
| 02/10/2000 | WO2000006563A1 Substituted imidazoles having cytokine inhibitory activity |
| 02/10/2000 | WO2000006561A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 02/10/2000 | WO2000006531A2 Nitric esters and nitrate salts of specific drugs |
| 02/10/2000 | WO2000006254A2 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications |
| 02/10/2000 | WO2000006198A2 Adjuvant comprising pulmonary surfactant |
| 02/10/2000 | WO2000006194A2 Depletion of cells responsible for antibody-mediated graft rejection |
| 02/10/2000 | WO2000006187A2 Modulation of apoptosis |
| 02/10/2000 | WO2000006178A1 EX VIVO TREATMENT OF ALLOGENEIC AND XENOGENEIC T-CELLS WITH gp39 ANTAGONISTS |
| 02/10/2000 | WO2000006153A1 Propenamides as ccr5 modulators |
| 02/10/2000 | WO2000006147A1 Macrophage scavenger receptor antagonists |
| 02/10/2000 | WO2000006146A1 Substituted anilide compounds and methods |
| 02/10/2000 | WO2000006137A2 Glucocorticoid-selective anti-inflammatory agents |
| 02/10/2000 | WO2000006121A1 Medicinal aerosol formulations |
| 02/10/2000 | WO2000006120A1 Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier |
| 02/10/2000 | WO2000006085A2 Compounds and methods |
| 02/10/2000 | WO2000000825A3 Detection and modulation of cellular immunity to immune privileged antigens |
| 02/10/2000 | WO1999067254A3 Multi-drug resistant retroviral protease inhibitors and use thereof |
| 02/10/2000 | WO1999065936A3 Composition for the treatement of immune deficiencies and methods for its preparation and use |
| 02/10/2000 | WO1999053038A3 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
| 02/10/2000 | WO1999049038A3 Human calcium-binding proteins |
| 02/10/2000 | WO1999036105A3 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE |
| 02/10/2000 | DE19835324A1 Cyclopentabenzofuran-Derivate und ihre Verwendung Cyclopentabenzofuran derivatives and their use |
| 02/10/2000 | CA2339096A1 Modulation of apoptosis |
| 02/10/2000 | CA2339094A1 Macrophage scavenger receptor antagonists |
| 02/10/2000 | CA2338870A1 Adjuvant comprising pulmonary surfactant |
| 02/10/2000 | CA2338804A1 Propenamides as ccr5 modulators |
| 02/10/2000 | CA2338773A1 Ex vivo treatment of allogeneic and xenogeneic t-cells with gp39 antagonists |
| 02/10/2000 | CA2338764A1 Substituted anilide compounds and methods |
| 02/10/2000 | CA2338697A1 Compounds and methods |
| 02/10/2000 | CA2338019A1 Prostate derived ets factor |
| 02/10/2000 | CA2337692A1 Kdel receptor inhibitors |
| 02/10/2000 | CA2335656A1 Human cytoskeletal proteins |
| 02/10/2000 | CA2335077A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 02/10/2000 | CA2333854A1 Stereoisomers of cpg oligonucleotides and related methods |
| 02/09/2000 | EP0978566A2 Chimaeric adenoviruses |
| 02/09/2000 | EP0978517A2 Triazolopurines, process for their preparation and their use as medicaments |
| 02/09/2000 | EP0978287A1 MEDICINAL COMPOSITION CONTAINING gp34 BINDING INHIBITOR AS THE ACTIVE INGREDIENT |
| 02/09/2000 | EP0978277A1 Antirheumatic agents |
| 02/09/2000 | EP0977872A1 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 02/09/2000 | EP0977859A1 The neurotrophic factor nnt-1 |
| 02/09/2000 | EP0977856A1 Lag-3 splice variants |
| 02/09/2000 | EP0977855A2 Polypeptides associated with activator receptors and their biological applications |
| 02/09/2000 | EP0977853A1 Secreted proteins and polynucleotides encoding them |
| 02/09/2000 | EP0977852A1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir) |
| 02/09/2000 | EP0977834A2 Human serine protease precursor |
| 02/09/2000 | EP0977777A1 A novel th2-specific gene |
| 02/09/2000 | EP0977756A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| 02/09/2000 | EP0977749A1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
| 02/09/2000 | EP0977741A1 Substituted phenyl derivatives, their preparation and use |
| 02/09/2000 | EP0977734A2 Arylsecocholadiene derivatives |
| 02/09/2000 | EP0977591A1 Costimulation of t-cell proliferation by a chimeric bispecific costimulatory protein |
| 02/09/2000 | EP0977586A1 Combinations of antigen and mucosal binding component for inducing specific immunological tolerance |
| 02/09/2000 | EP0977570A1 Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as medicines for treating aids |
| 02/09/2000 | EP0977569A1 Pharmaceutical composition for supressing type 2 helper t cell immune response |
| 02/09/2000 | EP0977568A1 Benzocycloheptathiophene compounds |
| 02/09/2000 | EP0977565A1 Pharmaceutical composition |
| 02/09/2000 | CN1244203A 抗原 Antigen |
| 02/09/2000 | CN1244130A Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 02/09/2000 | CN1244128A Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens |
| 02/09/2000 | CN1243827A Preparation of heterocyclic amide derivative with specific physical status |
| 02/09/2000 | CN1243751A Method for induction of immunity against virus |
| 02/09/2000 | CN1243741A Analgesic for treating rheumatic and rheumtoid diseases |
| 02/08/2000 | US6022978 Benzimidazole derivatives |
| 02/08/2000 | US6022971 Azetidines |
| 02/08/2000 | US6022969 Symmetrical bis(aminoalkyl), bis(amidinoalkyl) and bis(guanidinoalkyl) cycloalkanes |
| 02/08/2000 | US6022884 Substituted pyridine compounds and methods of use |
| 02/08/2000 | US6022876 L-β-dioxolane uridine analogs and methods for treating and preventing Epstein-Barr virus infections |
| 02/08/2000 | US6022864 Nucleic acid respiratory syncytial virus vaccines |
| 02/08/2000 | US6022848 Inhibitor of stem cell proliferation and uses thereof |
| 02/08/2000 | US6022697 Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus |
| 02/08/2000 | US6022694 Assay for ligands to tyrosine kinase receptors |
| 02/08/2000 | US6022692 Diagnosis of cancer in humans; screening sample with nucleotide sequences associated with cancer, hybridizing, the formation of hybridization complexes is indicative of cancer potential |
| 02/08/2000 | US6022544 Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry |
| 02/08/2000 | CA2150016C Pyrrolopyrimidines as crf antagonists |
| 02/08/2000 | CA2004206C Method for preparing pertussis toxin toxoid |
| 02/03/2000 | WO2000005388A1 Genes of the dead box protein family, their expression products and use |
| 02/03/2000 | WO2000005374A2 Molecules associated with cell proliferation |
| 02/03/2000 | WO2000005371A1 Keratinocyte derived interferon |
| 02/03/2000 | WO2000005362A1 Mekk1(serine threonine kinases)-interacting fha (forkhead associated domain) protein 1 (mif1) |
| 02/03/2000 | WO2000005268A1 Hybrid human/rodent igg antibody to cd3, and methods of its construction |
| 02/03/2000 | WO2000005265A2 Anti-crr2 antibodies and methods of use therefor |
| 02/03/2000 | WO2000005259A1 Secreted cysteine rich protein-6 (scrp-6) |
| 02/03/2000 | WO2000005254A2 Novel peptides for use in immunotherapy of autoimmune diseases |
| 02/03/2000 | WO2000005249A2 Synthetic peptides and methods of use for autoimmune disease therapies |
| 02/03/2000 | WO2000005246A1 Thioazepinone derivatives, preparation method and intermediates therefor, use as medicines and pharmaceutical compositions containing same |
| 02/03/2000 | WO2000005232A1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 02/03/2000 | WO2000005224A2 Heterocyclic derivatives and their use as integrin inhibitor |